Pharmagreen Biotech Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Pharmagreen Biotech Inc (PHBI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Peer Data As of Q4 2023
Competitors
-
Peer Group Market Share
100.00 %
Revenue Growth Y/Y
-
Net Margin
-27,287.27 %
Key Findings: Pharmagreen Biotech Inc vs Its Competitors
- Peer revenue share: Pharmagreen Biotech Inc accounted for 100.0% of combined revenue among its tracked peer group.
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
PHBI Sales vs. its Competitors, Q4 2023
Pharmagreen Biotech Inc generated 100.00 % of the combined sales of its peer group.
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/PHBI/competitors
https://api.csimarket.com/api/v1/companies/PHBI/relationships
https://api.csimarket.com/api/v1/companies/PHBI/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Connect Your AI Assistant
PHBI Stock Performance relative to its Competitors
PHBI
Competitors (weighted)
Percent change over the selected range